Genesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Long-Term Care Facilities
- Sub-Industry: N/A
- Symbol: NYSE:GEN
- CUSIP: N/A
- Web: www.genesishcc.com
- Market Cap: $172.48 million
- Outstanding Shares: 92,731,000
- 50 Day Moving Avg: $2.35
- 200 Day Moving Avg: $3.28
- 52 Week Range: $1.38 - $4.75
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.84
- P/E Growth: -0.16
- Annual Revenue: $5.54 billion
- Price / Sales: 0.03
- Book Value: ($5.94) per share
- Price / Book: -0.31
- EBIDTA: $503.52 million
- Net Margins: -6.10%
- Return on Assets: -0.72%
- Debt-to-Equity Ratio: -6.84%
- Current Ratio: 1.29%
- Quick Ratio: 1.29%
- Average Volume: 208,678 shs.
- Beta: 1.69
- Short Ratio: 1.07
Frequently Asked Questions for Genesis Healthcare (NYSE:GEN)
What is Genesis Healthcare's stock symbol?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."
How were Genesis Healthcare's earnings last quarter?
Genesis Healthcare Inc (NYSE:GEN) posted its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.25. The business earned $1.39 billion during the quarter, compared to analysts' expectations of $1.40 billion. During the same quarter last year, the firm earned ($0.48) EPS. View Genesis Healthcare's Earnings History.
Where is Genesis Healthcare's stock going? Where will Genesis Healthcare's stock price be in 2017?
2 brokers have issued 1 year price objectives for Genesis Healthcare's shares. Their forecasts range from $1.80 to $3.50. On average, they expect Genesis Healthcare's share price to reach $2.65 in the next twelve months. View Analyst Ratings for Genesis Healthcare.
Who are some of Genesis Healthcare's key competitors?
Some companies that are related to Genesis Healthcare include Accuray Incorporated (ARAY), Pacific Biosciences of California (PACB), RadNet (RDNT), Agenus (AGEN), Aurinia Pharmaceuticals (AUPH), Advaxis (ADXS), ChemoCentryx (CCXI), Corbus Pharmaceuticals Holdings (CRBP), Aquinox Pharmaceuticals (AQXP), Oxford Immunotec Global PLC (OXFD), GlycoMimetics (GLYC), Ocular Therapeutix (OCUL), SurModics (SRDX), Zogenix (ZGNX), Nantkwest (NK), Merus NV (MRUS), Minerva Neurosciences (NERV) and Edge Therapeutics (EDGE).
Who owns Genesis Healthcare stock?
Genesis Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional investors include
(8.50%), Columbia Pacific Advisors LLC (5.76%), HighTower Advisors LLC (3.58%), First Washington CORP (1.58%) and JPMorgan Chase & Co. (1.11%). Company insiders that own Genesis Healthcare stock include Daniel Allen Hirschfeld, George V Hager Jr, James V Mckeon, Joanne Susan Reifsnyder, Michael Scott Sherman, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.
Who sold Genesis Healthcare stock? Who is selling Genesis Healthcare stock?
Genesis Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Dimensional Fund Advisors LP, Teachers Advisors LLC and Forward Management LLC. Company insiders that have sold Genesis Healthcare stock in the last year include Daniel Allen Hirschfeld, George V Hager Jr, Joanne Susan Reifsnyder, Michael Scott Sherman, Stephen Scott Young and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.
Who bought Genesis Healthcare stock? Who is buying Genesis Healthcare stock?
Genesis Healthcare's stock was purchased by a variety of institutional investors in the last quarter, including Columbia Pacific Advisors LLC, JPMorgan Chase & Co., Renaissance Technologies LLC, First Washington CORP, Acadian Asset Management LLC, Citadel Advisors LLC, TFS Capital LLC and Oxford Asset Management. Company insiders that have bought Genesis Healthcare stock in the last two years include James V Mckeon and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.
How do I buy Genesis Healthcare stock?
Shares of Genesis Healthcare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Genesis Healthcare stock cost?
One share of Genesis Healthcare stock can currently be purchased for approximately $1.86.
Earnings History for Genesis Healthcare (NYSE:GEN)Earnings History by Quarter for Genesis Healthcare (NYSE:GEN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/9/2017||Q1 17||($0.25)||($0.50)||$1.40 billion||$1.39 billion||View||Listen|
|11/3/2016||Q3||($0.40)||($0.23)||$1.39 billion||$1.42 billion||View||N/A|
|8/4/2016||Q2||$0.01||($0.26)||$1.40 billion||$1.44 billion||View||N/A|
|5/9/2016||Q1||$0.03||($0.01)||$1.43 billion||$1.47 billion||View||N/A|
|11/5/2015||Q315||$0.07||$0.07||$1.42 billion||$1.42 billion||View||N/A|
|8/6/2015||Q215||$0.09||$0.14||$1.43 billion||$1.41 billion||View||N/A|
|2/19/2015||Q412||$0.14||$0.14||$209.50 million||$1.19 billion||View||N/A|
Earnings Estimates for Genesis Healthcare (NYSE:GEN)
Current Year EPS Consensus Estimate: $-1.22 EPS
Next Year EPS Consensus Estimate: $-1.01 EPS
Dividend History for Genesis Healthcare (NYSE:GEN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Genesis Healthcare (NYSE:GEN)
Insider Ownership Percentage: 73.28%Insider Trades by Quarter for Genesis Healthcare (NYSE:GEN)
Institutional Ownership Percentage: 10.38%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/29/2016||Stephen Scott Young||VP||Sell||10,000||$2.38||$23,800.00|| |
|6/8/2016||Daniel Allen Hirschfeld||COO||Sell||3,009||$1.72||$5,175.48|| |
|6/8/2016||George V Hager Jr||CEO||Sell||6,031||$1.72||$10,373.32|| |
|6/8/2016||Joanne Susan Reifsnyder||EVP||Sell||2,207||$1.72||$3,796.04|| |
|6/8/2016||Michael Scott Sherman||SVP||Sell||1,919||$1.72||$3,300.68|| |
|6/8/2016||Stephen Scott Young||VP||Sell||1,621||$1.72||$2,788.12|| |
|6/8/2016||Thomas Divittorio||CFO||Sell||3,051||$1.72||$5,247.72|| |
|11/12/2015||James V Mckeon||Director||Buy||10,000||$4.15||$41,500.00|| |
|11/11/2015||Thomas Divittorio||CFO||Buy||20,000||$4.34||$86,800.00|| |
Headline Trends for Genesis Healthcare (NYSE:GEN)
Latest Headlines for Genesis Healthcare (NYSE:GEN)
|ETFs with exposure to Genesis Healthcare, Inc. : May 26, 2017|
finance.yahoo.com - May 26 at 6:04 PM
|Columbia Pacific Advisors, LLC Buys ModSys International, Genesis Healthcare Inc, SPDR S&P ... - Nasdaq|
www.nasdaq.com - May 19 at 10:12 PM
|Columbia Pacific Advisors, LLC Buys ModSys International, Genesis ... - Nasdaq|
www.nasdaq.com - May 17 at 10:29 AM
|ETFs with exposure to Genesis Healthcare, Inc. : May 15, 2017|
finance.yahoo.com - May 15 at 4:59 PM
|Genesis Healthcare Reports First Quarter 2017 Results - Nasdaq|
www.nasdaq.com - May 10 at 5:31 PM
|Genesis Healthcare Inc (GEN) Posts Quarterly Earnings Results|
www.americanbankingnews.com - May 10 at 2:26 PM
|Edited Transcript of GEN earnings conference call or presentation 9-May-17 2:00pm GMT|
finance.yahoo.com - May 10 at 10:58 AM
|Genesis Healthcare, Inc. :GEN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017|
finance.yahoo.com - May 10 at 10:58 AM
|BRIEF-Genesis Healthcare says Qtrly loss from continuing operations $0.55 per common share|
www.reuters.com - May 9 at 11:38 AM
|EARNINGS SUMMARY: Details of Genesis Healthcare Inc. Q1 Earnings Report|
www.rttnews.com - May 9 at 11:38 AM
|Genesis Healthcare Reports First Quarter 2017 Results|
finance.yahoo.com - May 9 at 11:38 AM
|Genesis Healthcare reports 1Q loss|
marketbeat.com - May 9 at 6:25 AM
|Genesis HealthCare to Release First Quarter 2017 Results on Tuesday, May 9, 2017|
finance.yahoo.com - May 5 at 5:35 PM
|ETFs with exposure to Genesis Healthcare, Inc. : May 2, 2017|
finance.yahoo.com - May 3 at 8:28 AM
|Genesis Healthcare (GEN) Given Daily Media Sentiment Score of 0.26|
www.americanbankingnews.com - May 1 at 4:52 PM
|Genesis Healthcare (GEN) Earning Somewhat Positive News Coverage, Analysis Finds|
www.americanbankingnews.com - April 26 at 6:00 PM
|Genesis Healthcare (GEN) Given News Impact Rating of 0.12|
www.americanbankingnews.com - April 21 at 3:55 PM
|Acute care provider Kindred Healthcare explores sale: sources|
www.reuters.com - April 20 at 10:31 PM
|American Renal Associates (ARA) Appoints Susanne Clark and Robert Fish to Board of Directors|
www.streetinsider.com - April 19 at 10:19 PM
|ETFs with exposure to Genesis Healthcare, Inc. : April 19, 2017|
finance.yahoo.com - April 19 at 5:18 PM
|Geriatric Care Services Market worth USD 1 Trillion by 2024: Global Market Insights, Inc.|
globenewswire.com - April 12 at 5:28 PM
|BRIEF-Genesis Healthcare says Steven Fishman to resign from board effective immediately|
www.reuters.com - April 7 at 10:19 PM
|ETFs with exposure to Genesis Healthcare, Inc. : April 7, 2017|
finance.yahoo.com - April 7 at 5:17 PM
|Fitch Rates Omega Healthcare's Senior Unsecured Notes 'BBB-'; Outlook Stable|
www.reuters.com - March 28 at 5:02 PM
|Genesis Healthcare To Present At Barclays Global Conference; Webcast At 9:30 AM|
www.nasdaq.com - March 16 at 4:19 PM
|GENESIS HEALTHCARE, INC. Financials|
finance.yahoo.com - March 10 at 6:32 PM
|GENESIS HEALTHCARE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits|
biz.yahoo.com - March 10 at 11:04 AM
|Genesis HealthCare to Present at the Barclays Global Healthcare Conference on March 16, 2017 - Yahoo Finance|
finance.yahoo.com - March 8 at 11:15 PM
|GENESIS HEALTHCARE, INC. Files SEC form 10-K, Annual Report|
biz.yahoo.com - March 6 at 5:03 PM
|Kindred Healthcare posts lower 4Q earnings, halts quarterly dividends|
www.bizjournals.com - February 28 at 5:33 PM
|Genesis HealthCare Raises Over $254,000 as a Gold Level National Team for Alzheimer’s Association Walk to End Alzheimer’s®|
finance.yahoo.com - February 27 at 7:08 PM
|Edited Transcript of GEN earnings conference call or presentation 23-Feb-17 1:30pm GMT|
finance.yahoo.com - February 23 at 10:23 PM
|Genesis Healthcare Services to merge with Hospice Cloud, a National HME Company|
finance.yahoo.com - February 23 at 5:22 PM
|GENESIS HEALTHCARE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and|
biz.yahoo.com - February 23 at 5:22 PM
|EARNINGS SUMMARY: Details of Genesis Healthcare Inc. Q4 Earnings Report|
www.rttnews.com - February 22 at 10:39 PM
|Genesis HealthCare Reports Fourth Quarter and Fiscal Year End 2016 Results|
us.rd.yahoo.com - February 22 at 10:39 PM
|6:31 pm Genesis Healthcare reports Q4 (Dec) results, revs in-line; guides FY17 revs below consensus|
us.rd.yahoo.com - February 22 at 10:39 PM
|Sabra Reports Fourth Quarter 2016 Results; Updates Genesis Sales Process|
globenewswire.com - February 22 at 5:38 PM
|Sandia Ridge Center Launches New Mental Health and Recovery Unit|
finance.yahoo.com - February 16 at 5:20 PM
|BRIEF-Genesis Healthcare and Kindred form strategic clinical collaboration - Reuters|
www.reuters.com - February 2 at 10:56 PM
|4:31 pm Genesis Healthcare and Kindred Healthcare (KND) announces a strategic clinical collaboration to improve quality, outcomes and care transitions across the post-acute continuum|
finance.yahoo.com - January 31 at 8:24 PM
Genesis Healthcare (GEN) Chart for Friday, May, 26, 2017